RE: Looks like a turn in the tide !!17 Feb 2022 08:57
Morning Castle - I take the below from the January RNS:
"Paraytec has designed a short prospective clinical study to evaluate the performance of the CX300, when measured not only against both PCR and lateral flow tests, but also by determining patient sample viral infectivity by culture on mammalian epithelial cells. This trial, which will monitor positive patients daily for up to 10 days, will enable the Paraytec team to establish the performance of the device in determining the presence of infectious virus, and is expected to start before the end of February."
This suggests the test is NOT ready for commercial virus testing yet - it still needs to get through these latest trials and pass before we can then start the process of certification, commercial rubber stamping etc. Obviously then we have to sign on the dotted line with a manufacturer or sell up... so some stuff needs to be done yet.
The Sepsis and Bladder Cancer work is interesting to me and I think actually the stuff that's a bit different and may be lucrative longer term.